Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour

A prospective, randomized, placebo-controlled multi-centre trial

Sang Gyun Kim, Ho June Song, Il Ju Choi, Won Young Cho, Jeong Hoon Lee, Bora Keum, Yongchan Lee, Jae Gyu Kim, Sue K. Park, Byung Joo Park, Hyun Chae Jung

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction: The role of Helicobacter pylori (. H. pylori) eradication has not been clarified in the healing of iatrogenic ulcer after endoscopic resection of gastric neoplasm. The aim of this study was to evaluate whether H. pylori eradication could facilitate the healing of iatrogenic ulcer after endoscopic resection of gastric neoplasm. Methods: A total of 232 patients with H. pylori-positive early gastric cancer or gastric adenoma underwent endoscopic resection and were randomly allocated to eradication or placebo group in a prospective, double-blinded, and placebo-controlled manner. The primary outcome was measured by healing rate of ulcer, and the secondary outcomes by reduction rate of ulcer size, relief rate from ulcer-related symptoms, and adverse event rates. Results: The healing rate of ulcer was 53% in eradication group and 51.6% in placebo group, respectively (. p value. =. 0.95). The reduction rate of ulcer size, relief rate from ulcer-related symptoms and adverse event rates were also not different between two groups. In multivariate analysis, initial ulcer size more than 3. cm and histology of cancer were significant factors affecting iatrogenic ulcer healing. Conclusions: H. pylori eradication did not facilitate iatrogenic ulcer healing at early and late phase after endoscopic resection of gastric neoplasm.

Original languageEnglish
Pages (from-to)385-389
Number of pages5
JournalDigestive and Liver Disease
Volume45
Issue number5
DOIs
Publication statusPublished - 2013 May 1

Fingerprint

Helicobacter pylori
Ulcer
Stomach
Placebos
Neoplasms
Stomach Neoplasms
Adenoma
Histology
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Kim, Sang Gyun ; Song, Ho June ; Choi, Il Ju ; Cho, Won Young ; Lee, Jeong Hoon ; Keum, Bora ; Lee, Yongchan ; Kim, Jae Gyu ; Park, Sue K. ; Park, Byung Joo ; Jung, Hyun Chae. / Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour : A prospective, randomized, placebo-controlled multi-centre trial. In: Digestive and Liver Disease. 2013 ; Vol. 45, No. 5. pp. 385-389.
@article{d1c21b469b0b4fa298d7a15d618647c2,
title = "Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: A prospective, randomized, placebo-controlled multi-centre trial",
abstract = "Introduction: The role of Helicobacter pylori (. H. pylori) eradication has not been clarified in the healing of iatrogenic ulcer after endoscopic resection of gastric neoplasm. The aim of this study was to evaluate whether H. pylori eradication could facilitate the healing of iatrogenic ulcer after endoscopic resection of gastric neoplasm. Methods: A total of 232 patients with H. pylori-positive early gastric cancer or gastric adenoma underwent endoscopic resection and were randomly allocated to eradication or placebo group in a prospective, double-blinded, and placebo-controlled manner. The primary outcome was measured by healing rate of ulcer, and the secondary outcomes by reduction rate of ulcer size, relief rate from ulcer-related symptoms, and adverse event rates. Results: The healing rate of ulcer was 53{\%} in eradication group and 51.6{\%} in placebo group, respectively (. p value. =. 0.95). The reduction rate of ulcer size, relief rate from ulcer-related symptoms and adverse event rates were also not different between two groups. In multivariate analysis, initial ulcer size more than 3. cm and histology of cancer were significant factors affecting iatrogenic ulcer healing. Conclusions: H. pylori eradication did not facilitate iatrogenic ulcer healing at early and late phase after endoscopic resection of gastric neoplasm.",
author = "Kim, {Sang Gyun} and Song, {Ho June} and Choi, {Il Ju} and Cho, {Won Young} and Lee, {Jeong Hoon} and Bora Keum and Yongchan Lee and Kim, {Jae Gyu} and Park, {Sue K.} and Park, {Byung Joo} and Jung, {Hyun Chae}",
year = "2013",
month = "5",
day = "1",
doi = "10.1016/j.dld.2012.12.009",
language = "English",
volume = "45",
pages = "385--389",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier",
number = "5",

}

Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour : A prospective, randomized, placebo-controlled multi-centre trial. / Kim, Sang Gyun; Song, Ho June; Choi, Il Ju; Cho, Won Young; Lee, Jeong Hoon; Keum, Bora; Lee, Yongchan; Kim, Jae Gyu; Park, Sue K.; Park, Byung Joo; Jung, Hyun Chae.

In: Digestive and Liver Disease, Vol. 45, No. 5, 01.05.2013, p. 385-389.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour

T2 - A prospective, randomized, placebo-controlled multi-centre trial

AU - Kim, Sang Gyun

AU - Song, Ho June

AU - Choi, Il Ju

AU - Cho, Won Young

AU - Lee, Jeong Hoon

AU - Keum, Bora

AU - Lee, Yongchan

AU - Kim, Jae Gyu

AU - Park, Sue K.

AU - Park, Byung Joo

AU - Jung, Hyun Chae

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Introduction: The role of Helicobacter pylori (. H. pylori) eradication has not been clarified in the healing of iatrogenic ulcer after endoscopic resection of gastric neoplasm. The aim of this study was to evaluate whether H. pylori eradication could facilitate the healing of iatrogenic ulcer after endoscopic resection of gastric neoplasm. Methods: A total of 232 patients with H. pylori-positive early gastric cancer or gastric adenoma underwent endoscopic resection and were randomly allocated to eradication or placebo group in a prospective, double-blinded, and placebo-controlled manner. The primary outcome was measured by healing rate of ulcer, and the secondary outcomes by reduction rate of ulcer size, relief rate from ulcer-related symptoms, and adverse event rates. Results: The healing rate of ulcer was 53% in eradication group and 51.6% in placebo group, respectively (. p value. =. 0.95). The reduction rate of ulcer size, relief rate from ulcer-related symptoms and adverse event rates were also not different between two groups. In multivariate analysis, initial ulcer size more than 3. cm and histology of cancer were significant factors affecting iatrogenic ulcer healing. Conclusions: H. pylori eradication did not facilitate iatrogenic ulcer healing at early and late phase after endoscopic resection of gastric neoplasm.

AB - Introduction: The role of Helicobacter pylori (. H. pylori) eradication has not been clarified in the healing of iatrogenic ulcer after endoscopic resection of gastric neoplasm. The aim of this study was to evaluate whether H. pylori eradication could facilitate the healing of iatrogenic ulcer after endoscopic resection of gastric neoplasm. Methods: A total of 232 patients with H. pylori-positive early gastric cancer or gastric adenoma underwent endoscopic resection and were randomly allocated to eradication or placebo group in a prospective, double-blinded, and placebo-controlled manner. The primary outcome was measured by healing rate of ulcer, and the secondary outcomes by reduction rate of ulcer size, relief rate from ulcer-related symptoms, and adverse event rates. Results: The healing rate of ulcer was 53% in eradication group and 51.6% in placebo group, respectively (. p value. =. 0.95). The reduction rate of ulcer size, relief rate from ulcer-related symptoms and adverse event rates were also not different between two groups. In multivariate analysis, initial ulcer size more than 3. cm and histology of cancer were significant factors affecting iatrogenic ulcer healing. Conclusions: H. pylori eradication did not facilitate iatrogenic ulcer healing at early and late phase after endoscopic resection of gastric neoplasm.

UR - http://www.scopus.com/inward/record.url?scp=84876719789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876719789&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2012.12.009

DO - 10.1016/j.dld.2012.12.009

M3 - Article

VL - 45

SP - 385

EP - 389

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 5

ER -